An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

About

Brief Summary

A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.

Primary Purpose

Treatment

Study Type

Interventional

Phase

Phase 2

Eligibility

Gender

All

Healthy Volunteers

No

Minimum Age

18 Years

Maximum Age

N/A

Inclusion Criteria:

Documented active diagnosis of colorectal cancer.
Cachexia defined by Fearon criteria of weight loss.
Signed informed consent.

Exclusion Criteria:

Current active reversible causes of decreased food intake.
Receiving tube feedings or parenteral nutrition at the time of Screening or Randomization.
Have cachexia caused by other reasons.

Not a fit? Find another study